WHO 2024 Hepatitis B Guidelines: No more gray zone for low- and middle-income countries? An evaluation
Shanmugam Saravanan, Ramachandran Vignesh, Esaki M Shankar, Raju Sivadoss, Sathasivam Sivamalar, Vijayakumar Velu, Pachamuthu Balakrishnan, Arcot R Venkateswaran · 2026
Read WHO 2024 Hepatitis B Guidelines: No more gray zone for low- and middle-income countries? An evaluation by Shanmugam Saravanan, Ramachandran Vignesh, Esaki M Shankar, Raju Sivadoss, Sathasivam Sivamalar, Vijayakumar Velu, Pachamuthu Balakrishnan, Arcot R Venkateswaran (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13473240.txt.
Description
Shanmugam Saravanan and co-authors review the 2024 World Health Organization rules for hepatitis B care in 2026. Hepatitis B is a liver virus that affects more than 254 million people worldwide. The new rules widen who can start antiviral drugs, with simpler age and test cutoffs. Many people once left in a gray zone, neither clearly sick nor clearly safe, can now qualify.
The review weighs what wider access means for poorer states with few labs and tight budgets. Dropping the need for costly virus-load tests could bring care to far more people. At the same time, the authors flag risks of treating too broadly, drug harm over long use, and cost strain. Readers get a balanced look at a policy shift that could close a large care gap.
Catalog record
| CREATOR | Shanmugam Saravanan, Ramachandran Vignesh, Esaki M Shankar, Raju Sivadoss, Sathasivam Sivamalar, Vijayakumar Velu, Pachamuthu Balakrishnan, Arcot R Venkateswaran |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 17 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |